用户名: 密码: 验证码:
Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments
详细信息    查看全文
  • 作者:Mark M Fukuda (1)
    Terry A Klein (2)
    Tadeusz Kochel (3)
    Talia M Quandelacy (1)
    Bryan L Smith
    Jeff Villinski (5)
    Delia Bethell (4)
    Stuart Tyner (4)
    Youry Se (4)
    Chanthap Lon (4)
    David Saunders (4)
    Jacob Johnson (5)
    Eric Wagar (6)
    Douglas Walsh (6)
    Matthew Kasper (7)
    Jose L Sanchez (1)
    Clara J Witt (1)
    Qin Cheng (8)
    Norman Waters (8)
    Sanjaya K Shrestha (4)
    Julie A Pavlin (4)
    Andres G Lescano (3)
    Paul CF Graf (3)
    Jason H Richardson (4)
    Salomon Durand (3)
    William O Rogers (7)
    David L Blazes (1)
    Kevin L Russell (1)
  • 刊名:BMC Public Health
  • 出版年:2011
  • 出版时间:December 2011
  • 年:2011
  • 卷:11
  • 期:2-supp
  • 全文大小:906KB
  • 参考文献:1. Morens DM, Folkers GK, Fauci AS: g class="a-plus-plus">The challenge of emerging and re-emerging infectious diseases.g> / Nature 2004,g class="a-plus-plus">430g>(6996)g class="a-plus-plus">:g>242-. g/10.1038/nature02759">CrossRef
    2. Russell P: / Communicable Diseases: Malaria. / Volume VI. Edited by: C. JB. Washington DC: Office of the Surgeon General, Department of the Army; 1963.
    3. g class="a-plus-plus">Malaria acquired in Haiti - 2010g> / MMWR Morb Mortal Wkly Rep g class="a-plus-plus">59g>(8)g class="a-plus-plus">:g>217-.
    4. Witt C: g class="a-plus-plus">The AFHSC/Division of GEIS Operations Predictive Surveillance Program: A Multidisciplinary Approach for the Early Detection and Response to Disease Outbreaks.g> 2010.
    5. Vijaykadga S, / et al.: g class="a-plus-plus">In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.g> / Trop Med Int Health 2006,g class="a-plus-plus">11g>(2)g class="a-plus-plus">:g>211-. g/10.1111/j.1365-3156.2005.01557.x">CrossRef
    6. Denis MB, / et al.: g class="a-plus-plus">Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.g> / Trop Med Int Health 2006,g class="a-plus-plus">11g>(12)g class="a-plus-plus">:g>1800-. g/10.1111/j.1365-3156.2006.01739.x">CrossRef
    7. Noedl H, / et al.: g class="a-plus-plus">Evidence of artemisinin-resistant malaria in western Cambodia.g> / N Engl J Med 2008,g class="a-plus-plus">359g>(24)g class="a-plus-plus">:g>2619-0. g/10.1056/NEJMc0805011">CrossRef
    8. Bethell D, S Y, Lon C, Socheat D, Saunders S, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, S S, Kuntawungin W, Surasri S, Lee S, Sarim S, Tyner S, Smith B, Fukuda M: g class="a-plus-plus">Dose-Dependant Risk of Neutropenia Following 7-day Courses of Artesunate Monotherapy in Cambodian Patients with Acute P. falciparum Malaria.g> / Clinical Infectious Diseases 2010, in press.
    9. Rogers WO, / et al.: g class="a-plus-plus">Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.g> / Malar J 2009, g class="a-plus-plus">8:g>10. g/10.1186/1475-2875-8-10">CrossRef
    10. Dondorp AM, / et al.: g class="a-plus-plus">Artemisinin resistance: current status and scenarios for containment.g> / Nat Rev Microbiol g class="a-plus-plus">8g>(4)g class="a-plus-plus">:g>272-0.
    11. Wootton JC, / et al.: g class="a-plus-plus">Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.g> / Nature 2002,g class="a-plus-plus">418g>(6895)g class="a-plus-plus">:g>320-. g/10.1038/nature00813">CrossRef
    12. Roper C, / et al.: g class="a-plus-plus">Intercontinental spread of pyrimethamine-resistant malaria.g> / Science 2004,g class="a-plus-plus">305g>(5687)g class="a-plus-plus">:g>1124. g/10.1126/science.1098876">CrossRef
    13. Amin AA, / et al.: g class="a-plus-plus">The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.g> / Malar J 2007, g class="a-plus-plus">6:g>72. g/10.1186/1475-2875-6-72">CrossRef
    14. Durand S, Cabezas C, Alvares Antonio C, Galves Montoya M, Montalvan C, McCollum A, Soberon V, Udhayakumar V, Lucas C, Graf P, Bacon D: g class="a-plus-plus">Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru.g> In / American Society of Tropical Medicine and Hygiene 58th Annual Meeting. American Society of Tropical Medicine and Hygiene: Washington DC; 2009.
    15. Durand S, Santolalla M, Salas C, Soberon V, Alvares Antonio C, Montalvan C, Galves Montoya M, McCollum A, Green M, Lucas C, Udhayakumar V, Graf P, Bacon D: g class="a-plus-plus">A Probable Case of Chloroquine-resistant Plasmodium vivax in the Peruvian Amazon.g> In / American Society of Tropical Medicine and Hygiene 58th Annual Meeting. American Society of Tropical Medicine and Hygiene: Washington DC; 2009.
    16. Lee SW, / et al.: g class="a-plus-plus">Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea.g> / Am J Trop Med Hyg 2009,g class="a-plus-plus">81g>(4)g class="a-plus-plus">:g>600-. g/10.4269/ajtmh.2009.09-0102">CrossRef
    17. Freedman DO, / et al.: g class="a-plus-plus">Spectrum of disease and relation to place of exposure among ill returned travelers.g> / N Engl J Med 2006,g class="a-plus-plus">354g>(2)g class="a-plus-plus">:g>119-0. g/10.1056/NEJMoa051331">CrossRef
    18. Phuong HL, / et al.: g class="a-plus-plus">Dengue as a cause of acute undifferentiated fever in Vietnam.g> / BMC Infect Dis 2006, g class="a-plus-plus">6:g>123. g/10.1186/1471-2334-6-123">CrossRef
    19. Doherty JF, Grant AD, Bryceson AD: g class="a-plus-plus">Fever as the presenting complaint of travellers returning from the tropics.g> / Qjm 1995,g class="a-plus-plus">88g>(4)g class="a-plus-plus">:g>277-1.
    20. Aguilar PV, / et al.: g class="a-plus-plus">Guaroa virus infection among humans in Bolivia and Peru.g> / Am J Trop Med Hyg g class="a-plus-plus">83g>(3)g class="a-plus-plus">:g>714-1.
    21. Pandey BD, / et al.: g class="a-plus-plus">First case of Dengue virus infection in Nepal.g> / Nepal Med Coll J 2004,g class="a-plus-plus">6g>(2)g class="a-plus-plus">:g>157-.
    22. Malla S, / et al.: g class="a-plus-plus">Identification of all dengue serotypes in Nepal.g> / Emerg Infect Dis 2008,g class="a-plus-plus">14g>(10)g class="a-plus-plus">:g>1669-0. g/10.3201/eid1410.080432">CrossRef
    23. Schmidt AC: g class="a-plus-plus">Response to dengue fever--the good, the bad, and the ugly?g> / N Engl J Med g class="a-plus-plus">363g>(5)g class="a-plus-plus">:g>484-.
    24. / Addressing Emerging Infectious Disease Threats: A Strategic Plan for the Department of Defense Walter Reed Army Institute of Research: Washington DC; 1998.
    25. g class="a-plus-plus">Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. Workshop Summaryg> In / Forum on Microbial Threats. Institute of Medicine of the National Academies: Washington, DC; 2008.
    26. Jones KE, / et al.: g class="a-plus-plus">Global trends in emerging infectious diseases.g> / Nature 2008,g class="a-plus-plus">451g>(7181)g class="a-plus-plus">:g>990-. g/10.1038/nature06536">CrossRef
    27. Song JW, / et al.: g class="a-plus-plus">Hemorrhagic fever with renal syndrome in 4 US soldiers, South Korea, 2005.g> / Emerg Infect Dis 2009,g class="a-plus-plus">15g>(11)g class="a-plus-plus">:g>1833-.
    28. Song JW, / et al.: g class="a-plus-plus">Characterization of Imjin virus, a newly isolated hantavirus from the Ussuri white-toothed shrew (Crocidura lasiura).g> / J Virol 2009,g class="a-plus-plus">83g>(12)g class="a-plus-plus">:g>6184-1. g/10.1128/JVI.00371-09">CrossRef
    29. Baek LJ, / et al.: g class="a-plus-plus">Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea.g> / J Med Virol 2006,g class="a-plus-plus">78g>(2)g class="a-plus-plus">:g>290-. g/10.1002/jmv.20538">CrossRef
    30. Song KJ, / et al.: g class="a-plus-plus">Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea.g> / J Gen Virol 2007,g class="a-plus-plus">88g>(Pt 11)g class="a-plus-plus">:g>3121-. g/10.1099/vir.0.83139-0">CrossRef
    31. Burnette WN, / et al.: g class="a-plus-plus">Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military.g> / Mil Med 2008,g class="a-plus-plus">173g>(2)g class="a-plus-plus">:g>174-1.
    32. Integrated Capabilities Development Team: / "Infectious Disease Threats to the US Military Prioritization Panel Results". Memorandum for Record, Fort Sam Houston, TX; 2010.
    33. Gu W, / et al.: g class="a-plus-plus">Fundamental issues in mosquito surveillance for arboviral transmission.g> / Trans R Soc Trop Med Hyg 2008,g class="a-plus-plus">102g>(8)g class="a-plus-plus">:g>817-2. g/10.1016/j.trstmh.2008.03.019">CrossRef
    34. Eisen L, / et al.: g class="a-plus-plus">ProactiveVector control strategies and improved monitoring and evaluation practices for dengue prevention.g> / J Med Entomol 2009,g class="a-plus-plus">46g>(6)g class="a-plus-plus">:g>1245-5. g/10.1603/033.046.0601">CrossRef
  • 作者单位:Mark M Fukuda (1)
    Terry A Klein (2)
    Tadeusz Kochel (3)
    Talia M Quandelacy (1)
    Bryan L Smith
    Jeff Villinski (5)
    Delia Bethell (4)
    Stuart Tyner (4)
    Youry Se (4)
    Chanthap Lon (4)
    David Saunders (4)
    Jacob Johnson (5)
    Eric Wagar (6)
    Douglas Walsh (6)
    Matthew Kasper (7)
    Jose L Sanchez (1)
    Clara J Witt (1)
    Qin Cheng (8)
    Norman Waters (8)
    Sanjaya K Shrestha (4)
    Julie A Pavlin (4)
    Andres G Lescano (3)
    Paul CF Graf (3)
    Jason H Richardson (4)
    Salomon Durand (3)
    William O Rogers (7)
    David L Blazes (1)
    Kevin L Russell (1)

    1. Armed Forces Health Surveillance Center, 2900 Linden Lane, Silver Spring, MD, 20910, USA
    2. Force Health Protection and Preventive Medicine, 65th Medical Brigade, Unit 15281, Seoul, APO AP 96205-5281, USA (Republic of Korea
    3. US Naval Medical Research Center Detachment (NMRCD), Centro Medico Naval ″CMST,- Av. Venezuela CDRA 36, Callao 2, Lima, Peru
    5. US Army Medical Research Unit Kenya, ATTN: MRU, United States Embassy, United Nations Avenue, Post Office Box 606, Village Market, 00621, Nairobi, Kenya
    4. US Army Medical Component Armed Forces Research Institute of the Medical Sciences, APO AP 96546, Bangkok, Thailand
    6. US Naval Medical Research Unit Number 3, Extension of Ramses Street, Adjacent to Abbassia Fever Hospital, 11517, Cairo, Egypt
    7. US Navy Medical Research Unit-2, U.S. Embassy Unit, 8166 Box P, APO AP 96546, Phnom Penh, Cambodia
    8. Australian Army Malaria Institute, Weary Dunlop Drive, Gallipoli Barracks, Enoggera, QLD 4051, Australia
  • ISSN:1471-2458
文摘
Vector-borne infections (VBI) are defined as infectious diseases transmitted by the bite or mechanical transfer of arthropod vectors. They constitute a significant proportion of the global infectious disease burden. United States (U.S.) Department of Defense (DoD) personnel are especially vulnerable to VBIs due to occupational contact with arthropod vectors, immunological naiveté to previously unencountered pathogens, and limited diagnostic and treatment options available in the austere and unstable environments sometimes associated with military operations. In addition to the risk uniquely encountered by military populations, other factors have driven the worldwide emergence of VBIs. Unprecedented levels of global travel, tourism and trade, and blurred lines of demarcation between zoonotic VBI reservoirs and human populations increase vector exposure. Urban growth in previously undeveloped regions and perturbations in global weather patterns also contribute to the rise of VBIs. The Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) and its partners at DoD overseas laboratories form a network to better characterize the nature, emergence and growth of VBIs globally. In 2009 the network tested 19,730 specimens from 25 sites for Plasmodium species and malaria drug resistance phenotypes and nearly another 10,000 samples to determine the etiologies of non-Plasmodium species VBIs from regions spanning from Oceania to Africa, South America, and northeast, south and Southeast Asia. This review describes recent VBI-related epidemiological studies conducted by AFHSC-GEIS partner laboratories within the OCONUS DoD laboratory network emphasizing their impact on human populations.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700